Cost-effectiveness of treating schizophrenia with atypical antipsychotics

被引：0
|
作者：
Lewis, M [1 ]
Frangou, S [1 ]
机构：
[1] Inst Psychiat, Sect Neurobiol Psychosis, London, England
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80332-8
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：338 / 339
页数：2
相关论文
共 50 条
  • [41] Addition of amisulpride to other atypical antipsychotics for treating resistant schizophrenia
    Garcia, MJM
    García, CGJC
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S498 - S498
  • [42] Atypical antipsychotics in the treatment of schizophrenia - Cost is a crucial issue
    Duggins, R
    Rhinds, D
    Hall, W
    BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 926 - 926
  • [43] Cost-effectiveness in the treatment of schizophrenia
    Knapp, MRJ
    EUROPEAN PSYCHIATRY, 1996, 11 (03) : 137 - 143
  • [44] ANALYSIS OF COST EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA BASED ON NNT (NUMBER NEEDED TREAT)
    Pereira, M.
    Duchesne, I
    VALUE IN HEALTH, 2009, 12 (07) : A521 - A521
  • [45] An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco
    Tazi, Ahmed
    Errachidi, Faouzi
    Sonawane, Dipesh
    Tahri, Ghizlane
    Rao, Sameer
    Mehta, Suyog
    ANNALS OF GENERAL PSYCHIATRY, 2024, 23 (01)
  • [46] COST-EFFECTIVENESS OF QUETIAPINE EXTENDED RELEASE VERSUS OTHER ATYPICAL ANTIPSYCHOTICS IN ACUTE BIPOLAR DEPRESSION
    Meier, G.
    Edwards, S. J.
    von Maltzahn, R.
    VALUE IN HEALTH, 2009, 12 (07) : A360 - A360
  • [47] COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS AS ADJUNCTIVE THERAPY IN ADULT PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Taneja, C.
    Oster, G.
    Jing, Y.
    Baker, R. A.
    Forbes, R. A.
    Papakostas, G., I
    VALUE IN HEALTH, 2010, 13 (03) : A113 - A113
  • [48] COST-EFFECTIVENESS OF ASENAPINE VERSUS ATYPICAL ANTIPSYCHOTICS USED IN TURKEY IN THE TREATMENT OF BIPOLAR I DISORDER
    Pala, M.
    Ozdemir, S.
    Ozdemir, O.
    VALUE IN HEALTH, 2013, 16 (07) : A548 - A548
  • [49] Establishing cost-effectiveness of atypical neuroleptics
    Robert, G
    Kennedy, P
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 103 - 104
  • [50] Cost-effectiveness of treating ocular hypertension
    Stewart, William C.
    Stewart, Jeanette A.
    Nassar, Qasiem J.
    Mychaskiw, Marko A.
    OPHTHALMOLOGY, 2008, 115 (01) : 94 - 98
12345